Atlas Trials

Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy

Clinical trial NCT02019784 · COMPLETED

Trial details

NCT number
NCT02019784
Sponsor
King's College Hospital NHS Trust
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Liver CirrhosisHepatoencephalopathy, Early Fatal Progressive
Start date
2015-01-01
Primary completion
2016-06-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.